Technical Analysis for MNOV - MediciNova, Inc.

Grade Last Price % Change Price Change
grade D 5.46 2.25% 0.12
MNOV closed unchanged on Friday, May 29, 2020, on 35 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical MNOV trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 2.25%
Bollinger Band Squeeze Range Contraction 2.25%
Fell Below 20 DMA Bearish 2.25%
Bollinger Band Squeeze Range Contraction 2.25%
Crossed Above 20 DMA Bullish -0.55%
180 Bullish Setup Bullish Swing Setup -0.55%
Bollinger Band Squeeze Range Contraction -0.55%
Fell Below 20 DMA Bearish 3.02%
Bollinger Band Squeeze Range Contraction 3.02%
Crossed Above 20 DMA Bullish -1.62%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.
Medicine Health Pain Medication Multiple Sclerosis Respiratory Therapy Asthma Serious Diseases Central Nervous System Disorders Pulmonology Solid Tumor Cancers Urinary Incontinence Interstitial Cystitis

Is MNOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.84
52 Week Low 2.79
Average Volume 182,947
200-Day Moving Average 6.48
50-Day Moving Average 4.84
20-Day Moving Average 5.40
10-Day Moving Average 5.38
Average True Range 0.35
ADX 15.76
+DI 20.69
-DI 19.68
Chandelier Exit (Long, 3 ATRs ) 4.80
Chandelier Exit (Short, 3 ATRs ) 5.97
Upper Bollinger Band 5.71
Lower Bollinger Band 5.10
Percent B (%b) 0.39
BandWidth 11.22
MACD Line 0.09
MACD Signal Line 0.13
MACD Histogram -0.0453
Fundamentals Value
Market Cap 187.26 Million
Num Shares 35.1 Million
EPS -0.29
Price-to-Earnings (P/E) Ratio -18.41
Price-to-Sales 0.00
Price-to-Book 6.66
PEG Ratio -0.91
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.69
Resistance 3 (R3) 5.65 5.51 5.63
Resistance 2 (R2) 5.51 5.42 5.52 5.61
Resistance 1 (R1) 5.42 5.36 5.47 5.46 5.59
Pivot Point 5.28 5.28 5.30 5.29 5.28
Support 1 (S1) 5.19 5.19 5.24 5.23 5.09
Support 2 (S2) 5.05 5.13 5.06 5.07
Support 3 (S3) 4.96 5.05 5.05
Support 4 (S4) 5.00